Department of Pharmacotherapy
Title: Associate Professor
L. S. Skaggs Pharmacy Institute Room 4980
Phone: (801) 587-7728
Fax: (801) 587-7923
Carrie McAdam Marx, MSCI, PhD, RPh, is an Associate Professor with the Department of Pharmacotherapy at the University of Utah. Dr. McAdam Marx has a BS in Pharmacy from the University of Kansas, an MS in Hospital Pharmacy from the University of Minnesota, and a PhD in Health Policy from the University of the Sciences Philadelphia. She subsequently earned a Master of Science in Clinical Investigation (MSCI) from the University of Utah as part of a NIH-sponsored KM1 Career Development Program in Translational Comparative Effectiveness Research (T-CER). Dr. McAdam Marx uses T-CER and pharmacoeconomic techniques to evaluate the impact of collaborative drug therapy management in patients with type 2 diabetes. Specifically, she evaluates how pharmacist-led medication management, disease education, medication counseling, when delivered as part of a patient-centered primary care team, improves patient outcomes. She has been awarded grants from the University of Utah, the Pharmaceutical Research Manufacturers Association (PhRMA) Foundation, and the American Association of Colleges of Pharmacy (AACP) to perform this research. Her effectiveness research is evolving to include implementation studies to identify the feasibility and sustainability of collaborative drug therapy management programs in the primary care setting. She also conducts retrospective CER studies in diabetes pharmacotherapy to support patient and population level decision-making. Prior to joining the University of Utah, Dr. McAdam-Marx held positions in the pharmaceutical industry where she focused on the development and delivery of disease management and appropriate use of medicines programs for third party payers, drug pricing, and managed care sales operations.